ArticlePsoriasiform Drug Eruption Secondary to Sorafenib: Case Series and Review of the LiteratureAuthor:Lloyd S. Miller, MD, PhDPublish date: September 19, 2019The expanding use of novel targeted anticancer agents such as sorafenib has led to an increasing number of dermatologic adverse events. This report...Read More
